Tell your member of Congress to support the Medicare Negotiation and Competitive Licensing Act to lower drug prices for the people who need help the most.
Por Pablo Downey
More and more senior citizens are living in poverty, stretched to the limit by medical costs. Serving Seniors, which serves more than 600,000 meals per year to low-income senior citizens, and operates multiple affordable senior housing units, aims to alleviate this pressure — but we can’t lower the drug prices that are driving so many of our clients to our doors in the first place.
You know who can? Congress.
Americans pay the highest prices in the world for prescription drugs ? over 40 percent more than Canadians and often three times more than the residents of many European countries ? and patients on Medicare aren’t immune to these skyrocketing costs.
That’s why many so many seniors like our client John are often forced to choose between food and their medications. John is 72 years old and currently homeless due to some unfortunate events in his life. He’s had two knee replacement surgeries, as well as a hip replacement. However, he is still in constant pain, and can’t afford his medication due to soaring drug prices. Even with his Medicare benefits, he can only afford to take half of his prescribed pain medication ? he often takes it once a day and skips the next.
It doesn’t have to be this way, but it currently is because Medicare doesn’t have the power to negotiate drug prices with pharmaceutical companies on behalf of its beneficiaries. This is due to a hidden provision in the (ironically named) Medicare Modernization Act. Among other things, this legislation places corporate middlemen called Pharmacy Benefit Managers (PBMs) in charge of negotiating drug prices through Medicare’s “Part D” plan. PBMs are for-profit companies, and they have to take their cut ? often at the expense of low-income seniors.
Here’s where Congress comes in. Members from Texas, Maryland and Vermont have put forward a bill in the U.S. House of Representatives that could change all that: the Medicare Negotiation and Competitive Licensing Act. It would put Medicare directly back in charge of demanding the lowest drug prices for Americans in need. Medicare has the biggest buying power of any health care coverage provider; so it doesn’t make sense that they can’t negotiate drug prices directly for citizens on fixed budgets who have spent their working lives contributing to Social Security and Medicare.
Serving Seniors supports this bill because of people like John. No person should have to choose between basic necessities like food and medicine. Our government needs to act on seniors’ behalf.
Although some might say that free market competition encourages drug companies to provide low prices, in reality the pharmaceutical industry is protected by complex patent laws, and drug makers often successfully block out competition from low-cost generic alternatives. Drug companies can lock in some of the highest profits of any industry, all at the expense of consumers, especially seniors.
The Medicare Negotiation and Competitive Licensing Act is a win-win for both senior citizens and the government. It gives Medicare the power to negotiate reasonable prescription drug prices on behalf of millions of Americans, lowering tax dollars to pay for care, and lowering copays for older, vulnerable Americans on fixed incomes.
Our request to you: find out who represents you in Congress and contact their office. Tell them to support the Medicare Negotiation and Competitive Licensing Act.
If you are a senior in need of assistance, would like more information for a loved one, or are interested in donating to Serving Seniors, please call us at 619-487-0608 or visit servingseniors.org.
— Durante más de dos décadas, Paul Downey ha sido un defensor nacional de las personas mayores de bajos ingresos. Es presidente y director ejecutivo de Serving Seniors, una agencia sin fines de lucro dedicada durante casi 50 años a mejorar la calidad de vida de las personas mayores de San Diego que viven en la pobreza.
